Cita APA

Mross, K., Richly, H., Fischer, R., Scharr, D., Büchert, M., Stern, A., . . . Scheulen, M. E. (2013). First-in-Human Phase I Study of PRS-050 (Angiocal), an Anticalin Targeting and Antagonizing VEGF-A, in Patients with Advanced Solid Tumors. Public Library of Science.

Chicago Style Citation

Mross, Klaus, Heike Richly, Richard Fischer, Dirk Scharr, Martin Büchert, Angelika Stern, Hendrik Gille, Laurent P. Audoly, i Max E. Scheulen. First-in-Human Phase I Study of PRS-050 (Angiocal), an Anticalin Targeting and Antagonizing VEGF-A, in Patients With Advanced Solid Tumors. Public Library of Science, 2013.

Cita MLA

Mross, Klaus, et al. First-in-Human Phase I Study of PRS-050 (Angiocal), an Anticalin Targeting and Antagonizing VEGF-A, in Patients With Advanced Solid Tumors. Public Library of Science, 2013.